The Netherlands Competition Authority establishes the illegal character of the resale prohibition imposed by a pharmaceutical company on hospitals (AstraZeneca)

NMA: PROHIBITION BY ASTRAZENECA ON SALES TO THIRD PARTIES CONTRAVENES COMPETITION ACT* The prohibition against supplying parties outside the premises of hospitals, imposed on hospitals and pharmacies by AstraZeneca, contravenes the Competition Act. NMa made this ruling in a decision relating to the medicine

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteur

Citation

Netherlands Competition Authority, The Netherlands Competition Authority establishes the illegal character of the resale prohibition imposed by a pharmaceutical company on hospitals (AstraZeneca), 9 juillet 2002, e-Competitions July 2002, Art. N° 65771

Visites 156

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues